The prognosis of haploidentical hematopoietic stem cell transplantation in infants and patients under 3 years old with acute leukemia.
Guan-Hua HuXiao-Hui ZhangYu WangLan-Ping XuXin-Lin HouYi-Fei ChengXiao-Jun HuangPublished in: Clinical transplantation (2024)
HID transplantation is potent and safe for infants and young patients with acute leukemia. Relapse is the primary cause of treatment failure.